Henan Lingrui Pharmaceutical Co.,Ltd.’s Net Profit Rose 24.7% in First Half of 2021

Henan Lingrui Pharmaceutical Co.,Ltd. (河南羚锐制药股份有限公司) (600285.SH) reported a net profit of 220.3 million yuan in the first half of 2021, up 24.7% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 15.4% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 40.2%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.